Abstract

There is much evidence to indicate that FEN-1 efficiently cleaves single-stranded DNA flaps but is unable to process double-stranded flaps or flaps adopting secondary structures. However, the absence of Fen1 in yeast results in a significant increase in trinucleotide repeat (TNR) expansion. There are then two possibilities. One is that TNRs do not always form stable secondary structures or that FEN-1 has an alternative approach to resolve the secondary structures. In the present study, we test the hypothesis that concerted action of exonuclease and gap-dependent endonuclease activities of FEN-1 play a role in the resolution of secondary structures formed by (CTG)n and (GAA)n repeats. Employing a yeast FEN-1 mutant, E176A, which is deficient in exonuclease (EXO) and gap endonuclease (GEN) activities but retains almost all of its flap endonuclease (FEN) activity, we show severe defects in the cleavage of various TNR intermediate substrates. Precise knock-in of this point mutation causes an increase in both the expansion and fragility of a (CTG)n tract in vivo. Taken together, our biochemical and genetic analyses suggest that although FEN activity is important for single-stranded flap processing, EXO and GEN activities may contribute to the resolution of structured flaps. A model is presented to explain how the concerted action of EXO and GEN activities may contribute to resolving structured flaps, thereby preventing their expansion in the genome.

Highlights

  • Neurological disorders, including Huntington disease, fragile X syndrome, myotonic dystrophy, and Friedreich’s ataxia [2]

  • Rad27-E176A Is Deficient in EXO and gap endonuclease (GEN) Activities— flap endonuclease (FEN)-1 possesses three activities that vary in efficacy, with FEN activity being the strongest and GEN activity being the weakest

  • Mutant Enzyme E176A Cannot Process (CTG)20 Hairpin These fold-back substrates are inhibitory to FEN activity, and a Structures as Efficiently as Wild Type Protein—We further high concentration of FEN-1 is needed to resolve these structested the defect in EXO and GEN activities of Rad27-E176A tures in vitro [48, 49]

Read more

Summary

Oligonucleotides used for the construction of nuclease substrates

BRF8-5 BRF8-20 CBRF140 CBRFG0 FLGT4 SHEN14 FLAPG1CS CBRFG4 CBRF132 CTG20 GTT20 ZFAD ZFBR2 FBR1G FLAP3B1 FPG2 ILT1 IL(T48).

Loop Loop Loop Loop Loop
EXPERIMENTAL PROCEDURES
RESULTS
Wild type
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call